AMRX
Price
$8.07
Change
-$0.06 (-0.74%)
Updated
Jun 25, 01:27 PM (EDT)
Capitalization
1.87B
43 days until earnings call
PBH
Price
$83.28
Change
-$1.39 (-1.64%)
Updated
Jun 25, 01:11 PM (EDT)
Capitalization
3.6B
36 days until earnings call
Interact to see
Advertisement

AMRX vs PBH

Header iconAMRX vs PBH Comparison
Open Charts AMRX vs PBHBanner chart's image
Amneal Pharmaceuticals
Price$8.07
Change-$0.06 (-0.74%)
Volume$585
Capitalization1.87B
Prestige Consumer Healthcare
Price$83.28
Change-$1.39 (-1.64%)
Volume$100
Capitalization3.6B
AMRX vs PBH Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. PBH commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and PBH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (AMRX: $8.13 vs. PBH: $84.67)
Brand notoriety: AMRX and PBH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 106% vs. PBH: 109%
Market capitalization -- AMRX: $1.87B vs. PBH: $3.6B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. PBH’s [@Pharmaceuticals: Other] market capitalization is $3.6B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whilePBH’s FA Score has 2 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • PBH’s FA Score: 2 green, 3 red.
According to our system of comparison, PBH is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while PBH’s TA Score has 3 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 4 bearish.
  • PBH’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than PBH.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +2.91% price change this week, while PBH (@Pharmaceuticals: Other) price change was +1.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.04%. For the same industry, the average monthly price growth was +12.70%, and the average quarterly price growth was +94.60%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

PBH is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.04% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.6B) has a higher market cap than AMRX($1.87B). AMRX has higher P/E ratio than PBH: AMRX (90.00) vs PBH (14.90). PBH YTD gains are higher at: 8.426 vs. AMRX (2.652). AMRX has higher annual earnings (EBITDA): 400M vs. PBH (10.8M). AMRX has more cash in the bank: 91.5M vs. PBH (63.6M). PBH has less debt than AMRX: PBH (1.21B) vs AMRX (2.75B). AMRX has higher revenues than PBH: AMRX (2.39B) vs PBH (1.13B).
AMRXPBHAMRX / PBH
Capitalization1.87B3.6B52%
EBITDA400M10.8M3,704%
Gain YTD2.6528.42631%
P/E Ratio90.0014.90604%
Revenue2.39B1.13B211%
Total Cash91.5M63.6M144%
Total Debt2.75B1.21B227%
FUNDAMENTALS RATINGS
AMRX vs PBH: Fundamental Ratings
AMRX
PBH
OUTLOOK RATING
1..100
7165
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
629
SMR RATING
1..100
9960
PRICE GROWTH RATING
1..100
5251
P/E GROWTH RATING
1..100
2428
SEASONALITY SCORE
1..100
n/a40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBH's Valuation (84) in the Pharmaceuticals Other industry is in the same range as AMRX (91) in the Pharmaceuticals Major industry. This means that PBH’s stock grew similarly to AMRX’s over the last 12 months.

PBH's Profit vs Risk Rating (9) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (62) in the Pharmaceuticals Major industry. This means that PBH’s stock grew somewhat faster than AMRX’s over the last 12 months.

PBH's SMR Rating (60) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (99) in the Pharmaceuticals Major industry. This means that PBH’s stock grew somewhat faster than AMRX’s over the last 12 months.

PBH's Price Growth Rating (51) in the Pharmaceuticals Other industry is in the same range as AMRX (52) in the Pharmaceuticals Major industry. This means that PBH’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's P/E Growth Rating (24) in the Pharmaceuticals Major industry is in the same range as PBH (28) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXPBH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
61%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
44%
Advances
ODDS (%)
Bullish Trend 23 days ago
80%
Bullish Trend 16 days ago
59%
Declines
ODDS (%)
Bearish Trend 21 days ago
78%
Bearish Trend 6 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
56%
Aroon
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
38%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MFSG25.750.44
+1.75%
MFS Active Growth ETF
USAI40.020.42
+1.06%
Pacer American Energy Independence ETF
DSEP41.980.33
+0.80%
FT Vest US Equity Dp Bffr ETF Sep
NVG11.790.01
+0.08%
Nuveen AMT-Free Municipal Credit Income Fund
XONE49.580.01
+0.02%
BondBloxx Bloomberg One YrTrgDurUSTrsETF

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+0.33%
PAHC - PBH
51%
Loosely correlated
+1.27%
VTRS - PBH
41%
Loosely correlated
+1.13%
ZTS - PBH
35%
Loosely correlated
+0.27%
AMRX - PBH
34%
Loosely correlated
+2.72%
IRWD - PBH
32%
Poorly correlated
+7.78%
More